2017
DOI: 10.1016/j.ijpharm.2017.02.022
|View full text |Cite
|
Sign up to set email alerts
|

Development and in vivo evaluation of an innovative “Hydrochlorothiazide-in Cyclodextrins-in Solid Lipid Nanoparticles” formulation with sustained release and enhanced oral bioavailability for potential hypertension treatment in pediatrics

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

16
54
1
1

Year Published

2018
2018
2024
2024

Publication Types

Select...
5
4

Relationship

1
8

Authors

Journals

citations
Cited by 63 publications
(72 citation statements)
references
References 45 publications
16
54
1
1
Order By: Relevance
“…A rather similar behavior ( Figure 2C) was observed for the series of products with SBEβCD. As previously observed by Cirri et al, 2017, the thermal profile of this CD showed a broad endothermic effect between 60 to 110 • C due to its dehydration, and another endothermic band between 250 and 280 • C, due to degradation phenomena [30]. All binary systems prepared with the different techniques showed the superimposition of HCT melting and CD decomposition phenomena, similar to that observed in the simple PM.…”
Section: Characterization Of the Drug-cd Binary Systemssupporting
confidence: 84%
“…A rather similar behavior ( Figure 2C) was observed for the series of products with SBEβCD. As previously observed by Cirri et al, 2017, the thermal profile of this CD showed a broad endothermic effect between 60 to 110 • C due to its dehydration, and another endothermic band between 250 and 280 • C, due to degradation phenomena [30]. All binary systems prepared with the different techniques showed the superimposition of HCT melting and CD decomposition phenomena, similar to that observed in the simple PM.…”
Section: Characterization Of the Drug-cd Binary Systemssupporting
confidence: 84%
“…Drug-loaded lipid nanoparticles could reduce chemical or enzymatic degradation of the drugs which are embedded in a lipid matrix. Lipid nanoparticles could promote lymphatic transport and can bypass the liver and avoid hepatic first pass effect( 50 51 52 130 131 ). Lipid nanoparticles advantages and disadvantages for oral route are listed in Table 3 .…”
Section: Lipid Nanoparticles Applications and Different Routes Of Admmentioning
confidence: 99%
“…The test tubes were observed for miscibility. (Marzia Cirri et al, 2017) Formulation of SLNs: Among the various methods available for the preparation of nanoparticles, High-pressure homogenization method has been used for years, and it is a powerful technique for the large scale production. So, this method is used in the preparation of SLNs in the present study.…”
Section: Preparation Of Gcv Loaded Solid Lipid Nanoparticlesmentioning
confidence: 99%